Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
[Vitamin D and cancers].
Presse Med. 2013 Oct;42(10):1405-11. doi: 10.1016/j.lpm.2013.07.013. Epub 2013 Sep 17.
Presse Med. 2013.
PMID: 24051164
Review.
French.
[Impact of the menstrual cycle on the quality of interpretation of the MRI result in the follow-up of women at genetic risk for breast].
de Kermadec E, Thomassin I, Daraï E, Kolanska K, Chabbert-Buffet N.
de Kermadec E, et al.
Gynecol Obstet Fertil Senol. 2021 Dec;49(12):923-929. doi: 10.1016/j.gofs.2021.03.024. Epub 2021 Mar 24.
Gynecol Obstet Fertil Senol. 2021.
PMID: 33771738
French.
Item in Clipboard
Fertility preservation in women with malignant and borderline ovarian tumors: Experience of the French ESGO-certified center and pregnancy-associated cancer network (CALG).
Geoffron S, Lier A, de Kermadec E, Sermondade N, Varinot J, Thomassin-Naggara I, Bendifallah S, Daraï E, Chabbert-Buffet N, Kolanska K.
Geoffron S, et al. Among authors: de kermadec e.
Gynecol Oncol. 2021 Jun;161(3):817-824. doi: 10.1016/j.ygyno.2021.03.030. Epub 2021 Apr 1.
Gynecol Oncol. 2021.
PMID: 33812696
Item in Clipboard
Fertility concerns and treatment decision-making among national sample of young women with breast cancer.
de Kermadec E, Zheng Y, Rosenberg S, Ruddy KJ, Ligibel JA, Emmons KM, Partridge AH.
de Kermadec E, et al.
Cancer Med. 2023 Dec 22;13(1):e6838. doi: 10.1002/cam4.6838. Online ahead of print.
Cancer Med. 2023.
PMID: 38131887
Free PMC article.
Item in Clipboard
Reply to Y. Yoshitomi et al.
Tolaney SM, De Kermadec E, Cohen P, Paux G, Wang L, Im SA.
Tolaney SM, et al. Among authors: de kermadec e.
J Clin Oncol. 2024 Jan 10;42(2):241-242. doi: 10.1200/JCO.23.01887. Epub 2023 Oct 30.
J Clin Oncol. 2024.
PMID: 37903319
No abstract available.
Item in Clipboard
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Tolaney SM, Chan A, Petrakova K, Delaloge S, Campone M, Iwata H, Peddi PF, Kaufman PA, De Kermadec E, Liu Q, Cohen P, Paux G, Wang L, Ternès N, Boitier E, Im SA.
Tolaney SM, et al. Among authors: de kermadec e.
J Clin Oncol. 2023 Aug 20;41(24):4014-4024. doi: 10.1200/JCO.22.02746. Epub 2023 Jun 22.
J Clin Oncol. 2023.
PMID: 37348019
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite